Old Web
English
Sign In
Acemap
>
Paper
>
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact
2019
I Convertino
Ersilia Lucenteforte
Lorenzoni
Giuseppe Turchetti
L. Trieste
Giuseppe Roberto
M. Cazzato
Marta Mosca
S. Ferraro
Luca Leonardi
Nicoletta Luciano
Rosa Gini
Corrado Blandizzi
M. Tuccori
Keywords:
Clinical Practice
Infliximab
Medicine
Biosimilar
health authority
Family medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]